Columbia University investigators report an increased risk of breast lymphomas after postmastectomy implant-based reconstruction, including anaplastic large-cell lymphoma and several B-cell and T-cell ...
Frontline brentuximab vedotin (BV) and CHP in patients (pts) with peripheral T-cell lymphoma (PTCL) with 10% CD30 expression: Primary analysis results from the phase 2 SGN35-032 study. Safety and ...
Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of ...
Columbia University investigators report an increased risk of breast lymphomas after postmastectomy implant-based reconstruction, including anaplastic large-cell lymphoma and several B-cell and T-cell ...
The Food and Drug Administration issued a warning Wednesday about a rare and deadly cancer linked to breast implants. The agency said at least 457 women in the U.S. have been diagnosed with anaplastic ...
The development of anaplastic large-cell lymphomas is a rare, but established, risk of post-mastectomy implant-based breast reconstruction. In this study, breast implants after mastectomy were also ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results